drugset / Trial / NCT00409799

Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting

NCT00409799 ↗

Phase 2 Completed 208 enrolled Kuros Biosurgery AG
RandomizedParallel-groupOpen-labelTreatment

Summary

For certain tibial plateau fractures the bone is compressed due to the force acting on the tibia during the accident. The void provoked by the compression of the bone is filled with an appropriate filling material and the fracture is fixated. I 0401 is a new bone graft substitute that has shown capacities to promote bone-healing. This study will test the safety and efficacy of I 0401 in the treatment of patients with tibial plateau fractures requiring grafting.

Timeline

Start
2006-11
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject I-0401 Unknown — —

Indications

No indication recorded.